Compare, Analyse Divis Laboratories with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs TEVA PHARMA (Israel) - Comparison Results

DIVIS LABORATORIES     Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DIVIS LABORATORIES   TEVA PHARMA
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-19
TEVA PHARMA
Dec-13
DIVIS LABORATORIES/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,6392,965-   
Low Rs1,1152,576-   
Sales per share (Unadj.) Rs186.31,701.8-  
Earnings per share (Unadj.) Rs51.0106.3-  
Cash flow per share (Unadj.) Rs57.3243.9-  
Dividends per share (Unadj.) Rs16.0093.06-  
Dividend yield (eoy) %1.23.4 34.6%  
Book value per share (Unadj.) Rs261.81,890.4-  
Shares outstanding (eoy) m265.47848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x7.41.6 454.0%   
Avg P/E ratio x27.026.1 103.7%  
P/CF ratio (eoy) x24.011.4 211.5%  
Price / Book Value ratio x5.31.5 358.9%  
Dividend payout %31.487.5 35.9%   
Avg Mkt Cap Rs m365,5922,349,435 15.6%   
No. of employees `00011.844.9 26.4%   
Total wages/salary Rs m5,4230-   
Avg. sales/employee Rs Th4,175.132,108.3 13.0%   
Avg. wages/employee Rs Th457.70-   
Avg. net profit/employee Rs Th1,141.82,005.8 56.9%   
INCOME DATA
Net Sales Rs m49,4631,443,107 3.4%  
Other income Rs m1,5560-   
Total revenues Rs m51,0191,443,107 3.5%   
Gross profit Rs m18,718395,196 4.7%  
Depreciation Rs m1,689116,648 1.4%   
Interest Rs m3528,345 0.1%   
Profit before tax Rs m18,551250,203 7.4%   
Minority Interest Rs m01,137 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-164,244 0.0%   
Tax Rs m5,023-3,055 -164.4%   
Profit after tax Rs m13,52790,150 15.0%  
Gross profit margin %37.827.4 138.2%  
Effective tax rate %27.1-1.2 -2,217.9%   
Net profit margin %27.36.2 437.8%  
BALANCE SHEET DATA
Current assets Rs m46,501974,669 4.8%   
Current liabilities Rs m8,468849,994 1.0%   
Net working cap to sales %76.98.6 890.0%  
Current ratio x5.51.1 478.9%  
Inventory Days Days13191 144.1%  
Debtors Days Days8696 89.5%  
Net fixed assets Rs m25,797471,350 5.5%   
Share capital Rs m5313,552 14.9%   
"Free" reserves Rs m68,9620-   
Net worth Rs m69,4931,603,018 4.3%   
Long term debt Rs m0737,892 0.0%   
Total assets Rs m80,3833,297,961 2.4%  
Interest coverage x531.09.8 5,403.6%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.60.4 140.6%   
Return on assets %16.93.6 469.6%  
Return on equity %19.55.6 346.1%  
Return on capital %26.74.9 542.3%  
Exports to sales %00-   
Imports to sales %24.60-   
Net fx Rs m28,8330-   
CASH FLOW
From Operations Rs m9,543229,956 4.1%  
From Investments Rs m-6,854-81,483 8.4%  
From Financial Activity Rs m-2,459-275,848 0.9%  
Net Cashflow Rs m230-127,375 -0.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 71.04 Rs / USD

Compare DIVIS LABORATORIES With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare DIVIS LABORATORIES With: SANOFI INDIA  FRESENIUS KABI ONCO.  ALKEM LABORATORIES  FULFORD INDIA  NATCO PHARMA  



Today's Market

Sensex Opens Higher; Consumer Durables and Energy Stocks Lead(09:30 am)

Asian share markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 1.7% while the Hang Seng is down 0.1%.

Related Views On News

DIVIS LABORATORIES 2018-19 Annual Report Analysis (Annual Result Update)

Oct 10, 2019 | Updated on Oct 10, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

DIVIS LABORATORIES Announces Quarterly Results (1QFY20); Net Profit Up 0.4% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 0.4% YoY). Sales on the other hand came in at Rs 11 bn (up 14.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY19); Net Profit Up 10.6% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 10.6% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Rebound Riches Could be Yours With These Stocks (Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DIVIS LABORATORIES SHARE PRICE


Oct 15, 2019 11:25 AM

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES 8-QTR ANALYSIS

COMPARE DIVIS LABORATORIES WITH

MARKET STATS